Ownership history in VANGUARD GROUP INC · 9 quarters on record
This page tracks every 13F SEC filing in which VANGUARD GROUP INC reported a position in VIVOS THERAPEUTICS INC (VVOS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 304,161 | +212,700 | +232.6% | 0.00% | $617K | $2.03 |
| 2025 Q3 | ADDED | 91,461 | +48,827 | +114.5% | 0.00% | $284K | $3.10 |
| 2025 Q2 | UNCHANGED | 42,634 | — | 0% | 0.00% | $135K | $3.16 |
| 2025 Q1 | ADDED | 42,634 | +32,055 | +303.0% | 0.00% | $122K | $2.85 |
| 2024 Q4 | UNCHANGED | 10,579 | — | 0% | 0.00% | $45K | $4.29 |
| 2024 Q3 | UNCHANGED | 10,579 | — | 0% | 0.00% | $28K | $2.61 |
| 2024 Q2 | UNCHANGED | 10,579 | — | 0% | 0.00% | $23K | $2.22 |
| 2024 Q1 | UNCHANGED | 10,579 | — | 0% | 0.00% | $51K | $4.83 |
| 2023 Q4 | INITIATED | 10,579 | — | — | 0.00% | $132K | — |
As of 2025 Q4 — sorted by position size